These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31741333)
61. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359 [TBL] [Abstract][Full Text] [Related]
62. Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation. Cui X; Luckenbaugh L; Bruss V; Hu J J Virol; 2015 Oct; 89(19):10064-72. PubMed ID: 26202253 [TBL] [Abstract][Full Text] [Related]
67. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586 [TBL] [Abstract][Full Text] [Related]
68. Regulatory elements of hepatitis B virus transcription. Moolla N; Kew M; Arbuthnot P J Viral Hepat; 2002 Sep; 9(5):323-31. PubMed ID: 12225325 [TBL] [Abstract][Full Text] [Related]
69. Alpha/beta interferon differentially modulates the clearance of cytoplasmic encapsidated replication intermediates and nuclear covalently closed circular hepatitis B virus (HBV) DNA from the livers of hepatocyte nuclear factor 1alpha-null HBV transgenic mice. Anderson AL; Banks KE; Pontoglio M; Yaniv M; McLachlan A J Virol; 2005 Sep; 79(17):11045-52. PubMed ID: 16103155 [TBL] [Abstract][Full Text] [Related]
70. siRNA combinations mediate greater suppression of hepatitis B virus replication in mice. Li G; Fu L; Jiang J; Ping Y; Huang Y; Wang Y Cell Biochem Biophys; 2014 Jul; 69(3):641-7. PubMed ID: 24549857 [TBL] [Abstract][Full Text] [Related]
71. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome. Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974 [TBL] [Abstract][Full Text] [Related]
72. Limited effects of fasting on hepatitis B virus (HBV) biosynthesis in HBV transgenic mice. Li L; Oropeza CE; Kaestner KH; McLachlan A J Virol; 2009 Feb; 83(4):1682-8. PubMed ID: 19073739 [TBL] [Abstract][Full Text] [Related]
73. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Reese V; Ondracek C; Rushing C; Li L; Oropeza CE; McLachlan A Int J Biochem Cell Biol; 2011 Feb; 43(2):230-7. PubMed ID: 19941970 [TBL] [Abstract][Full Text] [Related]
75. Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection. Yan Y; Qiu Y; Davgadorj C; Zheng C Front Cell Infect Microbiol; 2022; 12():847539. PubMed ID: 35252042 [TBL] [Abstract][Full Text] [Related]
76. Unveiling the roles of HBV polymerase for new antiviral strategies. Clark DN; Hu J Future Virol; 2015; 10(3):283-295. PubMed ID: 25893003 [TBL] [Abstract][Full Text] [Related]
77. Gene therapeutic approaches to inhibit hepatitis B virus replication. Gebbing M; Bergmann T; Schulz E; Ehrhardt A World J Hepatol; 2015 Feb; 7(2):150-64. PubMed ID: 25729471 [TBL] [Abstract][Full Text] [Related]
80. Immunopathogenesis of HBV Infection. Wu J; Han M; Li J; Yang X; Yang D Adv Exp Med Biol; 2020; 1179():71-107. PubMed ID: 31741334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]